• CellGenix Expands Facility contractpharma
    October 15, 2020
    ​CellGenix GmbH, a global supplier of raw and ancillary materials for cell and gene therapies, has completed the second phase of its facility expansion.
  • BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1 contractpharma
    October 15, 2020
    ​BryoLogyx has completed the synthesis of bryostatin-1 molecule, pursuant to FDA’s Good Manufacturing Practice (GMP) regulations.
  • Arranta Bio Establishes Commercial-Ready Manufacturing Facility contractpharma
    September 30, 2020
    Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.
  • BioNTech to Acquire GMP Manufacturing Site americanpharmaceuticalreview
    September 27, 2020
    BioNTech announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.
  • JanOne Prepares for GMP Production contractpharma
    September 17, 2020
    Bottling and labeling of clinical trial batches are expected to begin in early October led by Eurofins CDMO.
  • Luina Bio Expands contractpharma
    September 02, 2020
    ​Luina Bio, one of Australia’s most experienced biopharmaceutical contract development and manufacturing (CDMO) organizations, is expanding to meet the increasing demand in the microbiome and recombinant biopharma markets.
  • JanOne Readies for Clinical GMP Manufacturing Run contractpharma
    August 21, 2020
    JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation.
  • Tetra Bio-Pharma and Dalton Pharma Enter GMP Manufacturing Tie-up contractpharma
    August 21, 2020
    Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product.
  • Swiss Parenterals receives EU GMP approval expresspharma
    August 10, 2020
    The manufacturer of sterile injectables is set to enter the EU markets with various range of injectables and has plans to expand gradually.
  • MilliporeSigma Opens M Lab Collaboration Center in Shanghai contractpharma
    July 13, 2020
    Offers customizable solutions to help advance drug development, including pilot scale and process development support labs that offer non-GMP lab space.
PharmaSources Customer Service